Haemolytic uraemic syndrome is an immune-mediated disease: role of anti-CD36 antibodies.
about
Pathophysiology of thrombotic thrombocytopenic purpuraCatastrophic relapse of Evans syndrome five years after allogeneic BMT notwithstanding full donor chimerism. Terminal hemolytic-uremic syndrome.Platelet interactions with viruses and parasites.Endothelium--role in regulation of coagulation and inflammation.
P2860
Haemolytic uraemic syndrome is an immune-mediated disease: role of anti-CD36 antibodies.
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Haemolytic uraemic syndrome is an immune-mediated disease: role of anti-CD36 antibodies.
@ast
Haemolytic uraemic syndrome is an immune-mediated disease: role of anti-CD36 antibodies.
@en
type
label
Haemolytic uraemic syndrome is an immune-mediated disease: role of anti-CD36 antibodies.
@ast
Haemolytic uraemic syndrome is an immune-mediated disease: role of anti-CD36 antibodies.
@en
prefLabel
Haemolytic uraemic syndrome is an immune-mediated disease: role of anti-CD36 antibodies.
@ast
Haemolytic uraemic syndrome is an immune-mediated disease: role of anti-CD36 antibodies.
@en
P2093
P2860
P1476
Haemolytic uraemic syndrome is an immune-mediated disease: role of anti-CD36 antibodies.
@en
P2093
Maria Kolajova
Marion Sternbach
Peter McLaine
William Clark
P2860
P304
P356
10.1111/J.1365-2141.2005.05761.X
P407
P577
2005-10-01T00:00:00Z